Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9064 | 1190 | 43.5 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
304 | 3 | P53//RETINOBLASTOMA//MDM2 | 40663 |
483 | 2 | CYCLIN DEPENDENT KINASE//CELL CYCLE//CDK5 | 15640 |
9064 | 1 | P21//P21WAF1 CIP1//P21WAF1 | 1190 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | P21 | authKW | 691415 | 19% | 12% | 228 |
2 | P21WAF1 CIP1 | authKW | 542446 | 8% | 23% | 93 |
3 | P21WAF1 | authKW | 259813 | 6% | 15% | 66 |
4 | WAF1 | authKW | 234561 | 2% | 38% | 24 |
5 | WAF1 CIP1 | authKW | 149281 | 1% | 73% | 8 |
6 | CIP1 | authKW | 140789 | 1% | 37% | 15 |
7 | P21 GENE | authKW | 125722 | 1% | 70% | 7 |
8 | SEZ PATOL GEN C GOLGI | address | 104766 | 1% | 58% | 7 |
9 | P21CIP1 WAF1 | authKW | 93532 | 2% | 19% | 19 |
10 | SDI1 | authKW | 80179 | 0% | 63% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7175 | 41% | 0% | 483 |
2 | Cell Biology | 4263 | 31% | 0% | 373 |
3 | Biochemistry & Molecular Biology | 1903 | 35% | 0% | 419 |
4 | Genetics & Heredity | 984 | 13% | 0% | 156 |
5 | Pathology | 464 | 6% | 0% | 74 |
6 | Biophysics | 147 | 5% | 0% | 61 |
7 | Medicine, Research & Experimental | 77 | 4% | 0% | 50 |
8 | Gastroenterology & Hepatology | 30 | 2% | 0% | 28 |
9 | Toxicology | 16 | 2% | 0% | 23 |
10 | Developmental Biology | 15 | 1% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SEZ PATOL GEN C GOLGI | 104766 | 1% | 58% | 7 |
2 | ZHANGHAI HOSP | 51317 | 0% | 100% | 2 |
3 | BIOL CELLULAIRE MOL CONTROLE PROLIFERAT CEL | 34210 | 0% | 67% | 2 |
4 | MINIST EDUC BREAST CANC PREVENT TREATME | 34210 | 0% | 67% | 2 |
5 | NEW PROD 4 | 32986 | 0% | 43% | 3 |
6 | BIOL MOL BIOMED BIOTECNOL CANTABRIA I | 25658 | 0% | 100% | 1 |
7 | CANC HOSP REPROD HERED | 25658 | 0% | 100% | 1 |
8 | CANC MOL BIOL GRP | 25658 | 0% | 100% | 1 |
9 | CELL CYCLE GEN STABIL | 25658 | 0% | 100% | 1 |
10 | CELL MOL BIOL GENE THER Y PROJECT | 25658 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR AND CELLULAR DIFFERENTIATION | 57139 | 1% | 32% | 7 |
2 | ONCOGENE | 14439 | 8% | 1% | 101 |
3 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 2262 | 2% | 0% | 21 |
4 | UROLOGIC ONCOLOGY | 2093 | 0% | 3% | 3 |
5 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1923 | 2% | 0% | 27 |
6 | CANCER RESEARCH | 1325 | 4% | 0% | 46 |
7 | MOLECULAR CARCINOGENESIS | 1313 | 1% | 0% | 12 |
8 | CELL GROWTH & DIFFERENTIATION | 1152 | 1% | 1% | 8 |
9 | MOLECULAR AND CELLULAR BIOLOGY | 859 | 2% | 0% | 28 |
10 | CLINICAL CANCER RESEARCH | 728 | 2% | 0% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P21 | 691415 | 19% | 12% | 228 | Search P21 | Search P21 |
2 | P21WAF1 CIP1 | 542446 | 8% | 23% | 93 | Search P21WAF1+CIP1 | Search P21WAF1+CIP1 |
3 | P21WAF1 | 259813 | 6% | 15% | 66 | Search P21WAF1 | Search P21WAF1 |
4 | WAF1 | 234561 | 2% | 38% | 24 | Search WAF1 | Search WAF1 |
5 | WAF1 CIP1 | 149281 | 1% | 73% | 8 | Search WAF1+CIP1 | Search WAF1+CIP1 |
6 | CIP1 | 140789 | 1% | 37% | 15 | Search CIP1 | Search CIP1 |
7 | P21 GENE | 125722 | 1% | 70% | 7 | Search P21+GENE | Search P21+GENE |
8 | P21CIP1 WAF1 | 93532 | 2% | 19% | 19 | Search P21CIP1+WAF1 | Search P21CIP1+WAF1 |
9 | SDI1 | 80179 | 0% | 63% | 5 | Search SDI1 | Search SDI1 |
10 | P21 WAF1 CIP1 SDI1 | 68420 | 0% | 67% | 4 | Search P21+WAF1+CIP1+SDI1 | Search P21+WAF1+CIP1+SDI1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CAZZALINI, O , SCOVASSI, AI , SAVIO, M , STIVALA, LA , PROSPERI, E , (2010) MULTIPLE ROLES OF THE CELL CYCLE INHIBITOR P21(CDKN1A) IN THE DNA DAMAGE RESPONSE.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 704. ISSUE 1-3. P. 12-20 | 96 | 64% | 133 |
2 | ABBAS, T , DUTTA, A , (2009) P21 IN CANCER: INTRICATE NETWORKS AND MULTIPLE ACTIVITIES.NATURE REVIEWS CANCER. VOL. 9. ISSUE 6. P. 400 -414 | 87 | 39% | 794 |
3 | GARTEL, AL , TYNER, AL , (2002) THE ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 IN APOPTOSIS.MOLECULAR CANCER THERAPEUTICS. VOL. 1. ISSUE 8. P. 639-649 | 91 | 54% | 620 |
4 | KREIS, NN , LOUWEN, F , YUAN, J , (2015) LESS UNDERSTOOD ISSUES: P21(CIP1) IN MITOSIS AND ITS THERAPEUTIC POTENTIAL.ONCOGENE. VOL. 34. ISSUE 14. P. 1758 -1767 | 84 | 50% | 15 |
5 | STIVALA, LA , CAZZALINI, O , PROSPERI, E , (2012) THE CYCLIN-DEPENDENT KINASE INHIBITOR P21(CDKN1A) AS A TARGET OF ANTI-CANCER DRUGS.CURRENT CANCER DRUG TARGETS. VOL. 12. ISSUE 2. P. 85 -96 | 77 | 54% | 29 |
6 | DUTTO, I , TILLHON, M , CAZZALINI, O , STIVALA, LA , PROSPERI, E , (2015) BIOLOGY OF THE CELL CYCLE INHIBITOR P21(CDKN1A): MOLECULAR MECHANISMS AND RELEVANCE IN CHEMICAL TOXICOLOGY.ARCHIVES OF TOXICOLOGY. VOL. 89. ISSUE 2. P. 155 -178 | 97 | 31% | 17 |
7 | ROMANOV, VS , POSPELOV, VA , POSPELOVA, TV , (2012) CYCLIN-DEPENDENT KINASE INHIBITOR P21(WAF1): CONTEMPORARY VIEW ON ITS ROLE IN SENESCENCE AND ONCOGENESIS.BIOCHEMISTRY-MOSCOW. VOL. 77. ISSUE 6. P. 575 -584 | 63 | 53% | 59 |
8 | WAGNER, M , KLUSSMANN, JP , FANGMANN, R , LINDER, R , ELEWA, ME , EIDT, S , ROSE, VMA , JUNGEHULSING, M , SCHULZE, HJ , (2001) CYCLIN-DEPENDENT KINASE-INHIBITOR 1 (CDKN1A) IN THE SQUAMOUS EPITHELIUM OF THE OROPHARYNX: POSSIBLE IMPLICATIONS OF MOLECULAR BIOLOGY AND COMPARTMENTATION.ANTICANCER RESEARCH. VOL. 21. ISSUE 1A. P. 333-345 | 100 | 54% | 5 |
9 | WEINBERG, WC , DENNING, MF , (2002) P21(WAF1) CONTROL OF EPITHELIAL CELL CYCLE AND CELL FATE.CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE. VOL. 13. ISSUE 6. P. 453-464 | 77 | 57% | 104 |
10 | RONINSON, IB , (2002) ONCOGENIC FUNCTIONS OF TUMOUR SUPPRESSOR P21 (WAF1/CIP1/SDI1): ASSOCIATION WITH CELL SENESCENCE AND TUMOUR-PROMOTING ACTIVITIES OF STROMAL FIBROBLASTS.CANCER LETTERS. VOL. 179. ISSUE 1. P. 1-14 | 63 | 48% | 251 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 5545 | SKP2//P27KIP1//P27 |
2 | 1581 | P53//P53 GENE//ONCOGENE |
3 | 5472 | CYCLIN D1//CCND1//CYCLIN D3 |
4 | 19975 | GADD45//GADD45A//GADD45 ALPHA |
5 | 23606 | CAK//SPY1//CDK ACTIVATING KINASE |
6 | 16830 | RAD P53//RECOMBINANT ADENOVIRUS P53//ADENOVIRAL MEDIATED INTERFERON ALPHA |
7 | 4549 | P16//CDKN2A//P16INK4A |
8 | 9053 | P53 POLYMORPHISM//P53 CODON 72//CODON 72 |
9 | 37546 | KIAA0101//NS5ATP9//OEATC 1 |
10 | 11121 | TUMOR FRONT GRADING//ORAL SQUAMOUS CELL CARCINOMA//P53 |